PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, United States; Section of Clinical Chemistry, Division of Laboratory Medicine, Department of Pathology, Texas Children\'s Hospital, Houston, TX 77030, United States.\', \'Section of Clinical Chemistry, Division of Laboratory Medicine, Department of Pathology, Texas Children\'s Hospital, Houston, TX 77030, United States.\', \'Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, United States.\', \'Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, United States; Section of Clinical Chemistry, Division of Laboratory Medicine, Department of Pathology, Texas Children\'s Hospital, Houston, TX 77030, United States. Electronic address: sxdevara@texaschildrens.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0009-9120(21)00249-610.1016/j.clinbiochem.2021.09.008
?:doi
?:hasPublicationType
?:journal
  • Clinical biochemistry
is ?:pmid of
?:pmid
?:pmid
  • 34560062
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 95
?:title
  • Analytical and clinical performance of cPass neutralizing antibodies assay.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34560062>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34560062>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all